[go: up one dir, main page]

DK1637517T3 - 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat - Google Patents

2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat

Info

Publication number
DK1637517T3
DK1637517T3 DK04746867.3T DK04746867T DK1637517T3 DK 1637517 T3 DK1637517 T3 DK 1637517T3 DK 04746867 T DK04746867 T DK 04746867T DK 1637517 T3 DK1637517 T3 DK 1637517T3
Authority
DK
Denmark
Prior art keywords
hydrogen atom
bicyclo
hexane
amino
alkyl group
Prior art date
Application number
DK04746867.3T
Other languages
English (en)
Inventor
Akito Yasuhara
Kazunari Sakagami
Hiroshi Ohta
Atsuro Nakazato
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1637517T3 publication Critical patent/DK1637517T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK04746867.3T 2003-06-26 2004-06-25 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat DK1637517T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2003181930 2003-06-26
JP2003373511 2003-10-31
JP2004128663 2004-04-23
PCT/JP2004/009398 WO2005000791A1 (ja) 2003-06-26 2004-06-25 2-アミノ-ビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸エステル誘導体

Publications (1)

Publication Number Publication Date
DK1637517T3 true DK1637517T3 (da) 2011-01-31

Family

ID=33556154

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04746867.3T DK1637517T3 (da) 2003-06-26 2004-06-25 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat
DK09166100.9T DK2123630T3 (da) 2003-06-26 2004-06-25 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK09166100.9T DK2123630T3 (da) 2003-06-26 2004-06-25 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarboxylsyreesterderivat

Country Status (20)

Country Link
US (5) US7960579B2 (da)
EP (3) EP2287147B1 (da)
JP (1) JP4792971B2 (da)
KR (1) KR101071507B1 (da)
AT (1) ATE487690T1 (da)
AU (2) AU2004252017B2 (da)
BR (1) BRPI0411823A (da)
CA (1) CA2530706C (da)
CY (1) CY1110997T1 (da)
DE (1) DE602004030007D1 (da)
DK (2) DK1637517T3 (da)
ES (1) ES2394175T3 (da)
HR (1) HRP20100619T1 (da)
MX (1) MXPA05013740A (da)
NO (1) NO335004B1 (da)
NZ (2) NZ544131A (da)
PL (1) PL1637517T3 (da)
PT (1) PT1637517E (da)
SI (1) SI1637517T1 (da)
WO (1) WO2005000791A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE487690T1 (de) * 2003-06-26 2010-11-15 Taisho Pharmaceutical Co Ltd 2-aminobicyclo 3.1.0 hexan-2,6- dicarbonsäureesterderivat
TW201129700A (en) 2009-11-18 2011-09-01 Taisho Pharmaceutical Co Ltd Method for producing optically active bicyclo [310] hexane derivative using oxygen
WO2011061935A1 (ja) * 2009-11-19 2011-05-26 大正製薬株式会社 3-アルコキシ-2-アミノ-6-フルオロビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸誘導体及びその中間体の製造方法
AR083845A1 (es) 2010-11-18 2013-03-27 Lilly Co Eli COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3
JP5870111B2 (ja) * 2010-11-18 2016-02-24 イーライ リリー アンド カンパニー mGluR2/3アンタゴニストとしての4−置換−3−ベンジルオキシ−ビシクロ[3.1.0]ヘキサン化合物
WO2013062680A1 (en) * 2011-10-25 2013-05-02 Braincells, Inc. Novel compounds and compositions thereof for treating nervous system disorders
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
JP5983713B2 (ja) * 2013-11-29 2016-09-06 大正製薬株式会社 含フッ素アミノ酸のプロドラッグを含有する医薬
FR3026843B1 (fr) * 2014-10-03 2016-11-18 Univ Pierre Et Marie Curie Paris 6 Procede de caracterisation du mecanisme de fissuration d'un materiau a partir de sa surface de rupture
AU2017254266B2 (en) 2016-04-18 2021-03-11 Taisho Pharmaceutical Co., Ltd. Prodrug of amino acid derivative
EP3570832A4 (en) 2017-01-17 2020-06-10 Board Of Regents, The University Of Texas System NOVEL COMPOUNDS USEFUL AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND / OR TRYPTOPHANE DIOXYGENASE
KR101877672B1 (ko) 2017-04-03 2018-07-11 엘에스산전 주식회사 Ad컨버터
US11046649B2 (en) 2018-07-17 2021-06-29 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US11501618B1 (en) * 2018-10-19 2022-11-15 Amazon Technologies, Inc. Security device with user-configurable motion detection settings
CN116444470B (zh) * 2023-03-29 2025-04-04 河南中烟工业有限责任公司 一种二羧酸二ddmp酯类化合物、制备方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
GB9605429D0 (en) 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
JP4194715B2 (ja) * 1998-08-31 2008-12-10 大正製薬株式会社 6−フルオロビシクロ[3.1.0]ヘキサン誘導体
CN1247527C (zh) 1998-08-31 2006-03-29 大正制药株式会社 6-氟双环[3.1.0]己烷衍生物
CH694053A5 (de) 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
CN1216038C (zh) * 2000-06-28 2005-08-24 大正制药株式会社 新型二羧酸衍生物
EP1370519A1 (en) * 2001-02-22 2003-12-17 Eli Lilly And Company Synthetic excitatory amino acids
RU2315622C2 (ru) 2001-12-27 2008-01-27 Тайсо Фармасьютикал Ко.,Лтд. Производные 6-фторбицикло[3.1.0]гексана
JP2007063129A (ja) * 2003-06-26 2007-03-15 Taisho Pharmaceut Co Ltd 2−アミノ−3−アルコキシビシクロ[3.1.0]ヘキサン誘導体
US7381746B2 (en) * 2003-06-26 2008-06-03 Taisho Pharmaceutical Co., Ltd. 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative
ATE487690T1 (de) * 2003-06-26 2010-11-15 Taisho Pharmaceutical Co Ltd 2-aminobicyclo 3.1.0 hexan-2,6- dicarbonsäureesterderivat

Also Published As

Publication number Publication date
ES2394175T3 (es) 2013-01-23
NZ580554A (en) 2011-01-28
CY1110997T1 (el) 2015-06-11
US8039647B2 (en) 2011-10-18
AU2004252017A1 (en) 2005-01-06
EP2123630B1 (en) 2012-07-25
PT1637517E (pt) 2011-01-31
AU2004252017B2 (en) 2009-10-08
US8258133B2 (en) 2012-09-04
EP2287147B1 (en) 2013-05-15
SI1637517T1 (sl) 2011-01-31
NZ544131A (en) 2009-11-27
CA2530706A1 (en) 2005-01-06
PL1637517T3 (pl) 2011-04-29
KR20060024817A (ko) 2006-03-17
NO20060428L (no) 2006-03-10
CA2530706C (en) 2012-11-27
US7960579B2 (en) 2011-06-14
HK1095318A1 (zh) 2007-05-04
DE602004030007D1 (en) 2010-12-23
WO2005000791A1 (ja) 2005-01-06
EP1637517B1 (en) 2010-11-10
DK2123630T3 (da) 2012-10-22
NO335004B1 (no) 2014-08-25
HRP20100619T1 (hr) 2011-01-31
AU2009217374A1 (en) 2009-10-08
KR101071507B1 (ko) 2011-10-10
EP2123630A1 (en) 2009-11-25
US20090306408A1 (en) 2009-12-10
MXPA05013740A (es) 2006-05-17
JPWO2005000791A1 (ja) 2006-10-19
JP4792971B2 (ja) 2011-10-12
ATE487690T1 (de) 2010-11-15
EP1637517A4 (en) 2007-05-23
EP2287147A3 (en) 2011-05-18
EP2287147A2 (en) 2011-02-23
EP1637517A1 (en) 2006-03-22
US8350060B2 (en) 2013-01-08
US20120028982A1 (en) 2012-02-02
AU2009217374B2 (en) 2011-03-03
US20070021394A1 (en) 2007-01-25
US20100298561A1 (en) 2010-11-25
BRPI0411823A (pt) 2006-08-08
US20120004232A1 (en) 2012-01-05
US8076502B2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
CY1110997T1 (el) Παραγωγο 2-αμινοδικυκλο [3.1.0] εξαν-2,6-δικαρβοξυλικου εστερα
MY139357A (en) Novel benzoimidazole derivatives useful as antiproliferative agents
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
MX2007004183A (es) Derivados de benzoimidazol utiles como agentes antiproliferacion.
ATE280170T1 (de) Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indole als 5ht2c antagonisten
BRPI0413876A (pt) tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos
EA200901162A1 (ru) Производные 1,4-дизамещённого 3-цианопиридона и их применение в качестве положительных модуляторов рецептора mglur2
TW200726765A (en) Triazolopyridine cannabinoid receptor 1 antagonists
NO20045103L (no) Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse
AP2002002664A0 (en) Cyclohexylamine derivative as subtype selective NMDA receptor antagonists.
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
ATE171374T1 (de) Verwendung von 1-(aminoalkyl)-3-quinoxalin-2-on derivaten zur herstellung von neuroprotektiven mitteln
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
MXPA05006271A (es) Metodo para el tratamiento de desordenes del movimiento usando derivados de acido barbiturico.
DE60135016D1 (de) Indolderivate und deren verwendung in medikamenten
ATE374366T1 (de) Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen
DK1082116T3 (da) Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme
ATE553087T1 (de) Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel
NO20053612L (no) 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet
ECSP992984A (es) Derivados de isotiazol utiles como agentes anticancerosos
TW200519099A (en) Novel amines as histamine-3 receptor ligands and their therapeutic applications